Clinical Trials Browser

Phase 1/2 × Recruiting × Solid Tumor × Clear all

NCT07556276 2026-04-29

Study of CMTS1215 Injection in Patients With Solid Tumors

Phase 1/2 Recruiting

Other solid neoplasm

Solid Tumor

NCT07258121 2026-04-28

Study of ZGGS34 in Participants With Advanced Solid Tumors

Phase 1/2 Recruiting

Other solid neoplasm

Solid Tumor

NCT04939610 2026-04-23

LuMIERE

Phase 1/2 Recruiting

Other solid neoplasm

Solid Tumor

NCT07446153 2026-04-03

A Clinical Study of HRS-8364 in the Treatment of Advanced Solid Tumor Subjects

Phase 1/2 Recruiting

Other solid neoplasm

Solid Tumor

NCT07229638 2026-03-20

A IB/II Phase Clinical Study on the Safety, Tolerability, and Efficacy of SHR-9839(sc) in Combination Anti-tumor Therapy in Patients With Solid Tumors

Phase 1/2 Recruiting

Other solid neoplasm

Solid Tumor

NCT07466160 2026-03-12

A Phase Ib/II Study of 7MW3711 Combined With JS207 in Advanced Solid Tumors

Phase 1/2 Recruiting

Other solid neoplasm

Solid Tumor

NCT06384807 2026-03-11

A Phase 1/2 Study of BHV-1510 (Previously PBI-410) in Advanced Solid Tumors

Phase 1/2 Recruiting

Other solid neoplasm

Solid Tumor

NCT07069062 2026-03-09

A Phase I/Ⅱ Human Study of HY0001a for Injection in Adult Participants With Advanced Solid Tumors

Phase 1/2 Recruiting

Other solid neoplasm

Solid Tumor

NCT06667960 2026-03-05

Study of JK06 in Patients With Unresectable Locally Advanced or Metastatic Cancer

Phase 1/2 Recruiting

Other solid neoplasm

Solid Tumor

NCT07392736 2026-02-06

A Phase I/IIa Study of AL8326 Combined With Toripalimab in the Treatment of Advanced Solid Tumors.

Phase 1/2 Recruiting

Other solid neoplasm

Solid Tumor

NCT07382531 2026-02-04

OH2 Injection in Combination With BS006 Injection for Advanced Solid Tumors

Phase 1/2 Recruiting

Other solid neoplasm

Solid Tumor

NCT05584670 2026-01-20

A First-in-human, Dose Escalation and Dose Expansion Study of SAR445877 in Adult Participants With Advanced Solid Tumors

Phase 1/2 Recruiting

Other solid neoplasm

Solid Tumor

NCT06712680 2025-12-23

A Phase I/II Study of HYP-6589 Monotherapy in Treating Advanced Solid Tumors and in Combination With Tyrosine Kinase Inhibitors in Treating Patients With Advanced NSCLC Positive for Driver Genes

Phase 1/2 Recruiting

Other solid neoplasm

Solid Tumor

NCT07229586 2025-12-19

A Study of SHR-7367 With Anti-tumor Agents in Patients With Solid Tumors

Phase 1/2 Recruiting

Other solid neoplasm

Solid Tumor

NCT06212076 2025-09-24

Phase I/II Study of IPG1094 in Advanced Solid Tumors Patients

Phase 1/2 Recruiting

Other solid neoplasm

Solid Tumor

NCT06468358 2025-09-11

TRIGGERCD8

Phase 1/2 Recruiting

Other solid neoplasm

Solid Tumor

NCT02992210 2025-09-08

Study on GD2 Positive Solid Tumors by 4SCAR-GD2

Phase 1/2 Recruiting

Other solid neoplasm

Solid Tumor

NCT06603844 2025-06-03

First-in-human Study of CRB-601-01 to Treat Patients With Advanced Solid Tumor.

Phase 1/2 Recruiting

Other solid neoplasm

Solid Tumor

NCT06234098 2025-05-02

Study to Investigate the Safety, Tolerability, Pharmacokinetics, Pharmocodynamics and Preliminary Antitumor Activity of AT-1965 in Patients With Advanced, Refractory or Recurrent Solid Tumors

Phase 1/2 Recruiting

Other solid neoplasm

Solid Tumor

NCT06016062 2025-01-23

A Study of RC148 As a Single Agent and Combination Therapy in Patients with Locally Advanced Unresectable or Metastatic Malignant Solid Tumors

Phase 1/2 Recruiting

Other solid neoplasm

Solid Tumor

NCT03707808 2025-01-20

myDAvIpNi

Phase 1/2 Recruiting

Other solid neoplasm

Solid Tumor

NCT06150885 2024-12-03

CAR001

Phase 1/2 Recruiting

Other solid neoplasm

Solid Tumor

NCT06117566 2024-11-25

A Study of WX390 Combined With Toripalimab in Patients With Advanced Solid Tumors

Phase 1/2 Recruiting

Other solid neoplasm

Solid Tumor

NCT06239298 2024-06-14

A Study of ZG005 Combined With Donafenib in Patients With Advanced Solid Tumor

Phase 1/2 Recruiting

Other solid neoplasm

Solid Tumor

NCT05923008 2023-11-29

A Clinical Study of IBI130 for Subjects With Unresectable, Locally Advanced or Metastatic Solid Tumors

Phase 1/2 Recruiting

Other solid neoplasm

Solid Tumor

NCT05909436 2023-06-18

Immuno-Oncology Drugs GLS-012 Alone & in Combination GLS-010 Treating With Advanced Patients Solid Tumors

Phase 1/2 Recruiting

Other solid neoplasm

Solid Tumor

NCT05437315 2022-06-29

GD2/PSMA Bi-specific CAR-T Cell Therapy

Phase 1/2 Recruiting

Other solid neoplasm

Solid Tumor